Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2025-07-02 09:24:25 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/s2213-8587(25)00141-x
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S221385872500141X
其他信息:
出版社: Elsevier BV
作者: Linong Ji; Leili Gao; Haibo Xue; Junhang Tian; Kun Wang; Hongwei Jiang; Chongbing Huang; Qiufang Lian; Mingxia Yuan; Ge Gao; Yibing Lu; Jie Han; Wenyan Fu; Haifang Wang; Yawei Zhang; Xiaoguang Shi; Binhong Wen; Bimin Shi; Wen Hu; Tonglan Guo; Ying Xing; Ya Li; Qingju Li; Qing Zheng; Ming Yang; Jing Ning; Mengying Guo; Yao Li; Hai Pan
